DK528386A - Proteinabsorptionsforoegende midler - Google Patents

Proteinabsorptionsforoegende midler

Info

Publication number
DK528386A
DK528386A DK528386A DK528386A DK528386A DK 528386 A DK528386 A DK 528386A DK 528386 A DK528386 A DK 528386A DK 528386 A DK528386 A DK 528386A DK 528386 A DK528386 A DK 528386A
Authority
DK
Denmark
Prior art keywords
protein absorption
preparing agents
absorption preparing
agents
protein
Prior art date
Application number
DK528386A
Other languages
English (en)
Other versions
DK528386D0 (da
Inventor
Stanley Jay Sarnoff
Burton E Sobel
Original Assignee
Survival Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/708,845 external-priority patent/US4661469A/en
Priority claimed from US06/782,441 external-priority patent/US4772585A/en
Application filed by Survival Technology filed Critical Survival Technology
Publication of DK528386D0 publication Critical patent/DK528386D0/da
Publication of DK528386A publication Critical patent/DK528386A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK528386A 1985-03-06 1986-11-05 Proteinabsorptionsforoegende midler DK528386A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/708,845 US4661469A (en) 1984-08-08 1985-03-06 t-PA composition capable of being absorbed into the blood stream and method of administration
US71670585A 1985-03-27 1985-03-27
US06/782,441 US4772585A (en) 1984-08-08 1985-10-01 Protein thrombolytic agent with absorption enhancing agent
PCT/US1986/000475 WO1986005096A1 (en) 1985-03-06 1986-03-06 Protein absorption enhancing agents

Publications (2)

Publication Number Publication Date
DK528386D0 DK528386D0 (da) 1986-11-05
DK528386A true DK528386A (da) 1986-11-05

Family

ID=27418848

Family Applications (1)

Application Number Title Priority Date Filing Date
DK528386A DK528386A (da) 1985-03-06 1986-11-05 Proteinabsorptionsforoegende midler

Country Status (9)

Country Link
EP (1) EP0214281B1 (da)
AT (1) ATE80306T1 (da)
AU (1) AU593794B2 (da)
DE (1) DE3686684T2 (da)
DK (1) DK528386A (da)
FI (1) FI864480A0 (da)
HU (1) HUT41632A (da)
NO (1) NO864382D0 (da)
WO (1) WO1986005096A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839170A (en) * 1985-10-01 1989-06-13 Survival Technology, Inc. Protein absorption enhancing agents
DE3544663A1 (de) * 1985-12-13 1987-06-19 Schering Ag Thrombosebehandlung mit fibrinolytika und prostacyclinen
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78571A (en) * 1985-04-22 1991-06-30 Genentech Inc Human tissue plasminogen activator mutants resistant to enzymatic cleavage resulting in two-chain form
NL8601354A (nl) * 1985-05-28 1986-12-16 Wellcome Found Nieuwe samenstelling.

Also Published As

Publication number Publication date
FI864480A (fi) 1986-11-04
DK528386D0 (da) 1986-11-05
DE3686684D1 (de) 1992-10-15
HUT41632A (en) 1987-05-28
ATE80306T1 (de) 1992-09-15
EP0214281B1 (en) 1992-09-09
WO1986005096A1 (en) 1986-09-12
EP0214281A1 (en) 1987-03-18
AU5581186A (en) 1986-09-24
EP0214281A4 (en) 1989-03-16
DE3686684T2 (de) 1993-01-28
FI864480A0 (fi) 1986-11-04
AU593794B2 (en) 1990-02-22
NO864382D0 (no) 1986-11-03
NO864382L (no) 1986-03-11

Similar Documents

Publication Publication Date Title
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DE3685625D1 (de) Antikoerperkomplexe von haptenmodifizierten diagnostischen oder therapeutischen mitteln.
DE3687741D1 (de) Geraet zur ultraschallechographie der bewegung von koerperorganen, insbesondere der blutstroemung oder des herzens.
NO833769L (no) Immunogent protein- eller peptidkompleks, fremgangsmaate for fremstilling og anvendelse herav som immunstimulerende middel og som vaksine
FI875533A0 (fi) Insulinpreparat foer non-parenteral dosering.
FI872756A (fi) Med laserstraolning fungerande terapeutisk anordning.
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DK528386A (da) Proteinabsorptionsforoegende midler
DE3862017D1 (de) Pharmazeutische zubereitung zur behandlung von tinea pedis.
ATE206458T1 (de) T-zellen stimulierendes protein von pestivirus
IL76121A0 (en) Protein absorption enhancing agents
FI92716C (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
FI885025A0 (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
DE3873825D1 (de) Die proteinabsorption verbessernde stoffe.
DK158985D0 (da) Konjugat af et protein med et cytotoksisk middel, fremgangsmaade til dets fremstilling og anvendelse heraf i reagenssaet til tumorbehandlingeller -analyse
NO872633D0 (no) Monoklonalt antistoff mot humant plasminogen, samt fremstilling derav.
IT8321962A0 (it) Siringa per la vaccinazione di animali in genere.
ES522243A0 (es) Procedimiento para la preparacion de mezclas de liquidos farmaceuticos,particularmente soluciones de infusion

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment